These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18725884)

  • 1. ERAAP prevents leader dominance?
    Colaco CA
    Immunol Cell Biol; 2008 Oct; 86(7):548. PubMed ID: 18725884
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't mess with ERAAP!
    Yewdell JW; Lu X
    Nat Immunol; 2012 May; 13(6):526-8. PubMed ID: 22610241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
    Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
    Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules.
    Nagarajan NA; de Verteuil DA; Sriranganadane D; Yahyaoui W; Thibault P; Perreault C; Shastri N
    J Immunol; 2016 Aug; 197(4):1035-43. PubMed ID: 27371725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum.
    Kanaseki T; Blanchard N; Hammer GE; Gonzalez F; Shastri N
    Immunity; 2006 Nov; 25(5):795-806. PubMed ID: 17088086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides.
    Hammer GE; Gonzalez F; James E; Nolla H; Shastri N
    Nat Immunol; 2007 Jan; 8(1):101-8. PubMed ID: 17128277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The final cut: how ERAP1 trims MHC ligands to size.
    Falk K; Rötzschke O
    Nat Immunol; 2002 Dec; 3(12):1121-2. PubMed ID: 12447365
    [No Abstract]   [Full Text] [Related]  

  • 8. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.
    Saric T; Chang SC; Hattori A; York IA; Markant S; Rock KL; Tsujimoto M; Goldberg AL
    Nat Immunol; 2002 Dec; 3(12):1169-76. PubMed ID: 12436109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.
    Cifaldi L; Lo Monaco E; Forloni M; Giorda E; Lorenzi S; Petrini S; Tremante E; Pende D; Locatelli F; Giacomini P; Fruci D
    Cancer Res; 2011 Mar; 71(5):1597-606. PubMed ID: 21252114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum.
    Serwold T; Gonzalez F; Kim J; Jacob R; Shastri N
    Nature; 2002 Oct; 419(6906):480-3. PubMed ID: 12368856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.
    York IA; Chang SC; Saric T; Keys JA; Favreau JM; Goldberg AL; Rock KL
    Nat Immunol; 2002 Dec; 3(12):1177-84. PubMed ID: 12436110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen Processing in the Endoplasmic Reticulum Is Monitored by Semi-Invariant αβ TCRs Specific for a Conserved Peptide-Qa-1
    Guan J; Yang SJ; Gonzalez F; Yin Y; Shastri N
    J Immunol; 2017 Mar; 198(5):2017-2027. PubMed ID: 28108559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective antitumor immunity through attenuation of ERAAP function.
    James E; Bailey I; Sugiyarto G; Elliott T
    J Immunol; 2013 Jun; 190(11):5839-46. PubMed ID: 23610143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide-based fluorescent probe images ERAAP activity in cells and in high throughput assays.
    Zhang J; Yang SJ; Gonzalez F; Yang J; Zhang Y; He M; Shastri N; Murthy N
    Chem Commun (Camb); 2018 Jun; 54(52):7215-7218. PubMed ID: 29897370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of the fitters.
    Rammensee HG
    Nature; 2002 Oct; 419(6906):443-5. PubMed ID: 12368840
    [No Abstract]   [Full Text] [Related]  

  • 17. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
    Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
    J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making sense of mass destruction: quantitating MHC class I antigen presentation.
    Yewdell JW; Reits E; Neefjes J
    Nat Rev Immunol; 2003 Dec; 3(12):952-61. PubMed ID: 14647477
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.
    Jösch C; Klotz LO; Sies H
    Biol Chem; 2003 Feb; 384(2):213-8. PubMed ID: 12675513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.